Current approaches to the management of multiple myeloma (MM), in particular the introduction of proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs), have improved the survival of patients.
Noa Biran
Articles by Noa Biran
Latest Updated Articles
Novel Targets in Relapsed and Relapsed/​Refractory Multiple MyelomaPublished: April 13th 2015 | Updated: